the website which has the background materials for these working groups in there, what we announced on the 20th of February.
The first one I'm just going to touch basically on is the contracts management. This group was set up to expedite external studies of key issues that need to be addressed under the initiative. Basically we're looking at two areas now, and we feel like we need help in the agency to really focus on these areas and that's why we're looking at having them done on contract. We're looking at effective quality systems practices. We want to sort of go out and look at those practices outside because obviously in setting up internal quality systems, we don't have all of the expertise inside of FDA to be able to put quality systems into practice within the agency. So we're going out to look at some of those and also to get a better handle on some of the areas that we need to focus on as far as with the industry on how we handle cGMPs and other product quality methodology.
So we'll be doing some contracts on this in the near future and from those contracts, we hope to learn a lot more on how we need to proceed in this area. As the